Видео ютуба по тегу Elraglusib

Targeting GSK-3ß with elraglusib in pancreatic cancer
Targeting GSK-3ß with elraglusib in pancreatic cancer
Elraglusib With Gem/Nab-Paclitaxel for Previously Untreated Metastatic Pancreatic Cancer
Elraglusib With Gem/Nab-Paclitaxel for Previously Untreated Metastatic Pancreatic Cancer
Evaluating the emerging role elraglusib as a treatment option in mPDCAC
Evaluating the emerging role elraglusib as a treatment option in mPDCAC
Analyzing responses and mechanisms of resistance to elraglusib
Analyzing responses and mechanisms of resistance to elraglusib
Pancreatic Cancer Breakthrough: 5x Survival Rate with New Drug Elraglusib!
Pancreatic Cancer Breakthrough: 5x Survival Rate with New Drug Elraglusib!
Elraglusib, a novel small molecule inhibitor of GSK-3
Elraglusib, a novel small molecule inhibitor of GSK-3
Phase II trial of elraglusib, a GSK-3ß inhibitor, in untreated mPDAC
Phase II trial of elraglusib, a GSK-3ß inhibitor, in untreated mPDAC
Phase I/II trial of elraglusib in solid tumors
Phase I/II trial of elraglusib in solid tumors
The anti-lymphoma effects of the GSK3 inhibitor elraglusib are not attributable to GSK3
The anti-lymphoma effects of the GSK3 inhibitor elraglusib are not attributable to GSK3
Impact of Erasglusib: Insights from Devalingam Mahalingam, MD, PhD
Impact of Erasglusib: Insights from Devalingam Mahalingam, MD, PhD
How Effective Is Chemotherapy For Pancreatic Cancer? - Pancreatic Health Network
How Effective Is Chemotherapy For Pancreatic Cancer? - Pancreatic Health Network
AACR25: Glenn Hanna, MD | Dana-Farber Cancer Institute
AACR25: Glenn Hanna, MD | Dana-Farber Cancer Institute
Actuate Therapeutics, Inc. (ACTU)
Actuate Therapeutics, Inc. (ACTU)
Dan Schmitt - President & CEO, Actuate Therapeutics, Inc. - Targeting Hard-To-Treat #Cancers
Dan Schmitt - President & CEO, Actuate Therapeutics, Inc. - Targeting Hard-To-Treat #Cancers
[LTRN Webinar] Actuate Therapeutics x Lantern Pharma AI Collaboration
[LTRN Webinar] Actuate Therapeutics x Lantern Pharma AI Collaboration
Inside the Data Driving Hope in Pancreatic Cancer | $ACTU | Actuate Therapeutics
Inside the Data Driving Hope in Pancreatic Cancer | $ACTU | Actuate Therapeutics
Enhancing anti-tumour activity: A post-ASCO conversation with Dan Schmitt
Enhancing anti-tumour activity: A post-ASCO conversation with Dan Schmitt
GSK3B and CHIR99021
GSK3B and CHIR99021
Как еда держит вирусы под контролем. Резистентные вирусы — зеркало образа жизни.
Как еда держит вирусы под контролем. Резистентные вирусы — зеркало образа жизни.
Growth of cancer market
Growth of cancer market
Создание перспективной линии противораковых препаратов на молекулярном уровне совместно с Дэном Ш...
Создание перспективной линии противораковых препаратов на молекулярном уровне совместно с Дэном Ш...
Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight
Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight